Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces Poster Presentations on XPHOZAH®…
Ardelyx, Inc. (NASDAQ: ARDX) Long Term Investor Notice: Lawsuit
Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial | PDF | Chronic Kidney Disease | Therapy
Ardelyx Inc.(NASDAQ: ARDX)-Can it Continue to Outdo Estimates?
Ardelyx, Inc. (NASDAQ:ARDX) Q3 2023 Earnings Call Transcript
Hyperphosphatemia Pipeline Insight Report 2023 (Updated)
ARDX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 28, 2021 in the Class Action Filed on Behalf of Ardelyx, Inc. Limited Shareholders
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ardelyx, Inc. (ARDX) Investigation
ARDX / Ardelyx, Inc. - Put/Call Ratio, Options Sentiment, Unusual Options Activity
News & Events | Ardelyx, Inc.
Ardelyx Provides Update on FDA Appeal for XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis
Ardelyx (@ardelyx) / X
Ardelyx, Inc. (ARDX) Stock Price, Quote & News - Stock Analysis
Ardelyx Announces Proposed Public Offering of Common Stock
Positive FDA AdCom votes for Ardelyx's tenapanor
Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page
SEC Filing | Ardelyx, Inc.
Ardelyx to Raise $110 Million in a Private Placement
Ardelyx
Ardelyx Prepares for Battle with FDA Over Rejected CKD Drug | BioSpace
Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces $20 Million Financing Agreement with…
Ardelyx wins FDA approval for phosphate absorption inhibitor - Pharmaceutical Technology
Ardelyx, Inc. (ARDX) Stock Price, Quote & News - Stock Analysis
FY2023 Earnings Forecast for Ardelyx, Inc. (NASDAQ:ARDX) Issued By Cantor Fitzgerald - MarketBeat
Ardelyx on X: "Press Release: FDA Grants Appeal for Ardelyx's XPHOZAH® (tenapanor) Read more here: https://t.co/drMd3jYvKl https://t.co/DYmGNsa9Nt" / X
Ardelyx
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities | Ardelyx, Inc.
Ardelyx: Q3 Earnings Snapshot -October 31, 2023 at 07:30 am EDT | MarketScreener
Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page
